{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:11:38Z","timestamp":1790284298407,"version":"4.1.0"},"reference-count":156,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>With increasing life expectancy driven by rapid biomedical science advancement, reproductive longevity has become a key concept in women\u2019s health. Preventing reproductive senescence is important not only to extend fertility potential but also to preserve endocrine health, enhance quality of life, and promote healthy aging. The end of ovarian function and fertility is symbolized by menopause, as the most eminent index of reproductive aging. Hormone replacement therapy (HRT) remains the mainstay for managing menopausal symptoms. However, as the use of HRT is often limited, there is a need for safe and effective alternatives. This narrative review summarizes current and emerging approaches targeting different stages of reproductive aging. Both hormonal and non-hormonal therapies for vasomotor and genitourinary symptoms are discussed alongside developing fertility preservation techniques, including oocyte vitrification, ovarian tissue cryopreservation, in vitro follicle maturation, and artificial ovary engineering. Furthermore, evolving and experimental ovarian regenerative strategies, such as stem cell transplantation, intraovarian platelet-rich plasma (PRP) injections, antioxidants, metabolic modulators, telomerase activators, and stem cell-derived extracellular vesicles, offer new prospects for delaying or reversing ovarian aging. Overall, personalized regenerative strategies and innovative solutions may reshape the future of women\u2019s reproductive health and longevity.<\/jats:p>","DOI":"10.3390\/medicina62010157","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:13:51Z","timestamp":1768299231000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reproductive Longevity: Innovative Approaches Beyond Hormone Replacement Therapy"],"prefix":"10.3390","volume":"62","author":[{"given":"Nida","family":"Jugulyt\u0117","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiva","family":"Bartkevi\u010dien\u0117","sequence":"additional","affiliation":[{"name":"Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2022.03.003","article-title":"Menopause transition: Physiology and symptoms","volume":"81","author":"Talaulikar","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101855","DOI":"10.1016\/j.beem.2023.101855","article-title":"Menopause: Physiology, definitions, and symptoms","volume":"38","author":"Gatenby","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/13697137.2011.650656","article-title":"Executive Summary of STRAW+10: Addressing the Unfinished Agenda of Staging Reproductive Aging","volume":"15","author":"Harlow","year":"2012","journal-title":"Climacteric J. Int. Menopause Soc."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fang, Y., Liu, F., Zhang, X., Chen, L., Liu, Y., Yang, L., Zheng, X., Liu, J., Li, K., and Li, Z. (2024). Mapping global prevalence of menopausal symptoms among middle-aged women: A systematic review and meta-analysis. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19280-5"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lu, J., Li, K., Zheng, X., Liu, R., Chen, M., Xian, J., Tu, S., and Xie, L. (2023). Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40\u201360 years: A cross-sectional study. BMC Womens Health, 23.","DOI":"10.1186\/s12905-023-02621-8"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/GME.0000000000001961","article-title":"Mental health and quality of life in post-menopausal women as a function of retrospective menopause symptom severity","volume":"29","author":"Hooper","year":"2022","journal-title":"Menopause"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/13697137.2018.1506435","article-title":"Optimizing quality of life in perimenopause: Lessons from the East","volume":"22","author":"Wang","year":"2019","journal-title":"Climacteric J. Int. Menopause Soc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Cagnacci, A., and Venier, M. (2019). The Controversial History of Hormone Replacement Therapy. Medicina, 55.","DOI":"10.3390\/medicina55090602"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Aquino, C.I., Stampini, V., Osella, E., Tro\u00eca, L., Rocca, C., Guida, M., Faggiano, F., Remorgida, V., and Surico, D. (2024). Menopausal Hormone Therapy, an Ever-Present Topic: A Pilot Survey about Women\u2019s Experience and Medical Doctors\u2019 Approach. Medicina, 60.","DOI":"10.3390\/medicina60050774"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.122.061559","article-title":"Rethinking Menopausal Hormone Therapy: For Whom, What, When and How long?","volume":"147","author":"Cho","year":"2023","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101577","DOI":"10.1016\/j.beem.2021.101577","article-title":"Menopausal hormone therapy and breast cancer risk","volume":"35","author":"Rozenberg","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-024-02590-1","article-title":"Menopausal hormone therapy and breast cancer risk: A population-based cohort study of 1.3 million women in Norway","volume":"131","author":"Vangen","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_13","first-page":"CD002229","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","volume":"2015","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/13697130903491018","article-title":"Adherence with hormone replacement therapy in menopause","volume":"13","author":"Fistonic","year":"2010","journal-title":"Climacteric"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/GME.0000000000002200","article-title":"The 2023 nonhormone therapy position statement of The North American Menopause Society","volume":"30","author":"Shufelt","year":"2023","journal-title":"Menopause"},{"key":"ref_16","first-page":"e46291","article-title":"Exploring the Complex Landscape of Delayed Childbearing: Factors, History, and Long-Term Implications","volume":"15","author":"Zabak","year":"2023","journal-title":"Cureus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/GCO.0b013e3283517908","article-title":"Delayed childbearing: Effects on fertility and the outcome of pregnancy","volume":"24","author":"Balasch","year":"2012","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.mayocp.2019.10.009","article-title":"Fertility Preservation in Women: Indications and Options for Therapy","volume":"95","author":"Hussein","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1530\/REP-17-0483","article-title":"Female fertility preservation: Past, present and future","volume":"156","author":"Fisch","year":"2018","journal-title":"Reproduction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13048-024-01492-3","article-title":"Stem cell-based therapeutic potential in female ovarian aging and infertility","volume":"17","author":"Cui","year":"2024","journal-title":"J. Ovarian Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s43043-021-00077-0","article-title":"Intraovarian platelet-rich plasma: Current status","volume":"26","author":"Elnashar","year":"2021","journal-title":"Middle East Fertil. Soc. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.18632\/aging.101784","article-title":"Can ovarian aging be delayed by pharmacological strategies?","volume":"11","author":"Zhang","year":"2019","journal-title":"Aging"},{"key":"ref_23","first-page":"1745506519864009","article-title":"Hormone therapy for first-line management of menopausal symptoms: Practical recommendations","volume":"15","author":"Palacios","year":"2019","journal-title":"Womens Health"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"(2020). The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause, 27, 976\u2013992.","DOI":"10.1097\/GME.0000000000001609"},{"key":"ref_25","first-page":"25","article-title":"Modern management of genitourinary syndrome of menopause","volume":"10","author":"Baines","year":"2021","journal-title":"Fac. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sarmento, A.C.A., Costa, A.P.F., Vieira-Baptista, P., Giraldo, P.C., Eleut\u00e9rio, J., and Gon\u00e7alves, A.K. (2021). Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic. Front. Reprod. Health, 3.","DOI":"10.3389\/frph.2021.779398"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/13697137.2012.756466","article-title":"Non-hormonal topical treatment of vulvovaginal atrophy: An up-to-date overview","volume":"16","author":"Sinha","year":"2013","journal-title":"Climacteric J. Int. Menopause Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/13697137.2015.1124259","article-title":"Treating vulvovaginal atrophy\/genitourinary syndrome of menopause: How important is vaginal lubricant and moisturizer composition?","volume":"19","author":"Edwards","year":"2016","journal-title":"Climacteric"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Iaconisi, G.N., Lunetti, P., Gallo, N., Cappello, A.R., Fiermonte, G., Dolce, V., and Capobianco, L. (2023). Hyaluronic Acid: A Powerful Biomolecule with Wide-Ranging Applications\u2014A Comprehensive Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210296"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/GME.0000000000001122","article-title":"Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: A phase 2 pilot study","volume":"25","author":"Hersant","year":"2018","journal-title":"Menopause"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00404-010-1382-8","article-title":"The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: A randomized controlled trial","volume":"283","author":"Ekin","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/jsm.12125","article-title":"Evaluation of the Efficacy and Safety of Hyaluronic Acid Vaginal Gel to Ease Vaginal Dryness: A Multicenter, Randomized, Controlled, Open-Label, Parallel-Group, Clinical Trial","volume":"10","author":"Chen","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.23736\/S2724-606X.21.04841-7","article-title":"Treatment of vulvo-vaginal atrophy with hyaluronate-based gel: A randomized controlled study","volume":"74","author":"Nappi","year":"2022","journal-title":"Minerva Obstet. Gynecol."},{"key":"ref_34","first-page":"571","article-title":"A comparison of hyaluronic acid and estradiol treatment in vulvovaginal atrophy","volume":"28","author":"Jafarzade","year":"2024","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Cuccu, I., Golia D\u2019Aug\u00e8, T., Firulli, I., De Angelis, E., Buzzaccarini, G., D\u2019Oria, O., Besharat, A.R., Caserta, D., Bogani, G., and Muzii, L. (2024). Update on Genitourinary Syndrome of Menopause: A Scoping Review of a Tailored Treatment-Based Approach. Life, 14.","DOI":"10.3390\/life14111504"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13697137.2023.2218998","article-title":"Different local estrogen therapies for a tailored approach to GSM","volume":"26","author":"Nappi","year":"2023","journal-title":"Climacteric"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/GME.0000000000001463","article-title":"Systemic estradiol levels with low-dose vaginal estrogens","volume":"27","author":"Santen","year":"2019","journal-title":"Menopause"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/GME.0000000000001221","article-title":"A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause","volume":"26","author":"Biehl","year":"2019","journal-title":"Menopause"},{"key":"ref_39","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"105509","DOI":"10.1016\/j.phrs.2021.105509","article-title":"The therapeutic effect of dehydroepiandrosterone (DHEA) on vulvovaginal atrophy","volume":"166","author":"Wang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/GME.0000000000001238","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"25","author":"Labrie","year":"2018","journal-title":"Menopause"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/AOG.0000000000005288","article-title":"Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause: A Systematic Review","volume":"142","author":"Hobson","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/GME.0000000000000470","article-title":"Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Farahat, R.A., Salamah, H.M., Mahmoud, A., Hamouda, E., Hashemy, M., Hamouda, H., Samir, A., Chenfouh, I., Marey, A., and Awad, D.M. (2023). The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: An updated systematic review and meta-analysis. BMC Womens Health, 23.","DOI":"10.1186\/s12905-023-02645-0"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zohrabi, I., Abedi, P., Ansari, S., Maraghi, E., Shakiba Maram, N., and Houshmand, G. (2020). The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: A randomized controlled trial. BMC Womens Health, 20.","DOI":"10.1186\/s12905-020-00935-5"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0092623X.2020.1738606","article-title":"The Impact of Oxytocin Vaginal Gel on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial","volume":"46","author":"Abedi","year":"2020","journal-title":"J. Sex Marital Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2147\/IJWH.S431520","article-title":"Ospemifene for Genitourinary Syndrome of Menopause: Patient Selection","volume":"16","author":"Marchetti","year":"2024","journal-title":"Int. J. Womens Health"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/GME.0000000000001292","article-title":"Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial","volume":"26","author":"Archer","year":"2019","journal-title":"Menopause"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/09513590.2017.1332589","article-title":"Effects of ospemifene on vaginal epithelium of post-menopausal women","volume":"33","author":"Alvisi","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/gme.0b013e31826d36ba","article-title":"Ospemifene Study Group One-year long-term safety extension study of ospemifene for the treatment of vulvar vaginal atrophy in postmenopausal women with a uterus","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"ref_53","first-page":"272","article-title":"Do SSRIs and SNRIs reduce the frequency and\/or severity of hot flashes in menopausal women","volume":"110","author":"Stubbs","year":"2017","journal-title":"J. Okla. State Med. Assoc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11606-013-2535-9","article-title":"SSRIs for Hot Flashes: A Systematic Review and Meta-Analysis of Randomized Trials","volume":"29","author":"Shams","year":"2014","journal-title":"J. Gen. Intern. Med."},{"key":"ref_55","first-page":"173","article-title":"The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials","volume":"47","author":"Azizi","year":"2022","journal-title":"Iran. J. Med. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/2327-6924.12137","article-title":"The efficacy and tolerability of SSRI\/SNRIs in the treatment of vasomotor symptoms in menopausal women: A systematic review","volume":"27","author":"Handley","year":"2015","journal-title":"J. Am. Assoc. Nurse Pract."},{"key":"ref_57","first-page":"1576359","article-title":"Laser Therapy in the Treatment of Female Urinary Incontinence and Genitourinary Syndrome of Menopause: An Update","volume":"2019","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jsxm.2021.12.010","article-title":"CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis","volume":"19","author":"Filippini","year":"2022","journal-title":"J. Sex. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/1471-0528.17195","article-title":"Laser treatment for genitourinary syndrome of menopause","volume":"129","author":"Phillips","year":"2022","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2021.06.005","article-title":"Vaginal laser therapy for genitourinary syndrome of menopause\u2014Systematic review","volume":"156","author":"Mension","year":"2022","journal-title":"Maturitas"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Jugulyt\u0117, N., \u017dukien\u0117, G., and Bartkevi\u010dien\u0117, D. (2023). Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina, 59.","DOI":"10.3390\/medicina59010132"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3332\/ecancer.2019.988","article-title":"A systematic review of laser therapy for vulvovaginal atrophy\/genitourinary syndrome of menopause in breast cancer survivors","volume":"13","author":"Knight","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33574\/hjog.1933","article-title":"Minimal invasive procedures for the treatment of genitourinary syndrome of menopause (GSM). Un. update","volume":"19","author":"Zacharakis","year":"2019","journal-title":"HJOG"},{"key":"ref_64","first-page":"e53316","article-title":"Role of Platelet-Rich Plasma in Genitourinary Syndrome of Menopause","volume":"16","author":"Waghe","year":"2024","journal-title":"Cureus"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s00266-023-03550-5","article-title":"Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review","volume":"47","author":"Moccia","year":"2023","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/13697137.2020.1863356","article-title":"The effects of phytoestrogens on postmenopausal health","volume":"24","author":"Rowe","year":"2021","journal-title":"Climacteric"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13697137.2014.966241","article-title":"Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review","volume":"18","author":"Chen","year":"2015","journal-title":"Climacteric"},{"key":"ref_68","first-page":"e37222","article-title":"Role of Phytoestrogen in Menopausal Women with Depressive Symptoms: A Consecutive Case Series Study","volume":"15","author":"Karalis","year":"2023","journal-title":"Cureus"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1089\/acm.2017.0118","article-title":"Effects of Phytoestrogens on Depressive Symptoms in Climacteric Women: A Meta-Analysis of Randomized Controlled Trials","volume":"24","author":"Su","year":"2018","journal-title":"J. Altern. Complement. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.AOG.0000140688.71638.d3","article-title":"Phytoestrogens for treatment of menopausal symptoms: A systematic review","volume":"104","author":"Krebs","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility Preservation in Women","volume":"377","author":"Donnez","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(14)60834-5","article-title":"Fertility preservation in women with cancer","volume":"384","author":"Smitz","year":"2014","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrendo.2013.205","article-title":"Fertility preservation in women","volume":"9","author":"Donnez","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13698","article-title":"Preservation of female fertility: The current therapeutic strategy","volume":"156","author":"Henry","year":"2022","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.fertnstert.2011.06.030","article-title":"Clinical application of oocyte vitrification: A systematic review and meta-analysis of randomized controlled trials","volume":"96","author":"Cobo","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/biolre\/ioab239","article-title":"The effects of vitrification on oocyte quality","volume":"106","author":"Chang","year":"2022","journal-title":"Biol. Reprod."},{"key":"ref_77","first-page":"e61963","article-title":"Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives","volume":"175","author":"Maggiulli","year":"2021","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.fertnstert.2015.11.027","article-title":"Oocyte vitrification as an efficient option for elective fertility preservation","volume":"105","author":"Cobo","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2019). Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: A committee opinion. Fertil. Steril., 112, 1022\u20131033.","DOI":"10.1016\/j.fertnstert.2019.09.013"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and Onco-fertility preservation: Factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/aogs.13559","article-title":"A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients\u2019 choices and benefit of the chosen methods after long-term follow up","volume":"98","author":"Marklund","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ramirez, T., and Pavone, M. (2024). Exploring the Frontiers of Ovarian Tissue Cryopreservation: A Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13154513"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Diaz, A.A., Kubo, H., Handa, N., Hanna, M., and Laronda, M.M. (2022). A Systematic Review of Ovarian Tissue Transplantation Outcomes by Ovarian Tissue Processing Size for Cryopreservation. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.918899"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.jpedsurg.2018.12.021","article-title":"Fertility and hormone preservation and restoration for female children and adolescents receiving gonadotoxic cancer treatments: A systematic review","volume":"54","author":"Corkum","year":"2019","journal-title":"J. Pediatr. Surg."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.ajog.2025.02.007","article-title":"Pregnancy outcomes following ovarian tissue cryopreservation: An Australian cohort study","volume":"233","author":"Finkelstein","year":"2025","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.fertnstert.2015.08.005","article-title":"Ovarian cortex transplantation: Time to move on from experimental studies to open clinical application","volume":"104","author":"Donnez","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/humrep\/dew165","article-title":"Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: Tissue activity, pregnancy and delivery rates","volume":"31","author":"Liebenthron","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s10815-015-0544-9","article-title":"Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice","volume":"32","author":"Donnez","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humupd\/dmac003","article-title":"Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: A systematic review and individual patient data meta-analysis","volume":"28","author":"Khattak","year":"2022","journal-title":"Hum. Reprod. Update"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/aogs.13735","article-title":"Ovarian tissue cryopreservation: Low usage rates and high live-birth rate after transplantation","volume":"99","author":"Hoekman","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12958-023-01167-6","article-title":"Assessing the impact of transplant site on ovarian tissue transplantation: A single-arm meta-analysis","volume":"21","author":"Xie","year":"2023","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Fabbri, R., Vicenti, R., Magnani, V., Paradisi, R., Lima, M., De Meis, L., Rossi, S., Raimondo, D., Casadio, P., and Venturoli, S. (2022). Ovarian tissue cryopreservation and transplantation: 20 years experience in Bologna University. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1035109"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.fertnstert.2021.03.004","article-title":"In vitro growth and maturation of primordial follicles and immature oocytes","volume":"115","author":"Telfer","year":"2021","journal-title":"Fertil. Steril."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Canosa, S., Revelli, A., Gennarelli, G., Cormio, G., Loizzi, V., Arezzo, F., Petracca, E.A., Carosso, A.R., Cimadomo, D., and Rienzi, L. (2023). Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis. Healthcare, 11.","DOI":"10.3390\/healthcare11202748"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/term.2870","article-title":"A new possibility in fertility preservation: The artificial ovary","volume":"13","author":"Cho","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12958-023-01092-8","article-title":"Artificial ovaries constructed from biodegradable chitin-based hydrogels with the ability to restore ovarian endocrine function and alleviate osteoporosis in ovariectomized mice","volume":"21","author":"Xiang","year":"2023","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"ref_97","first-page":"477","article-title":"The Artificial Ovary: The Next Step in Fertility Preservation in Cancer Patients","volume":"18","author":"Varlas","year":"2023","journal-title":"Maedica"},{"key":"ref_98","first-page":"e63072","article-title":"Revolutionizing Reproduction: The Impact of Robotics and Artificial Intelligence (AI) in Assisted Reproductive Technology: A Comprehensive Review","volume":"16","author":"Mapari","year":"2024","journal-title":"Cureus"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.surg.2024.02.005","article-title":"The integration of artificial intelligence in robotic surgery: A narrative review","volume":"176","author":"Zhang","year":"2024","journal-title":"Surgery"},{"key":"ref_100","first-page":"e81568","article-title":"Artificial Intelligence in Assisted Reproductive Technology: A New Era in Fertility Treatment","volume":"17","author":"Orovou","year":"2025","journal-title":"Cureus"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/REP-18-0523","article-title":"Artificial intelligence in reproductive medicine","volume":"158","author":"Wang","year":"2019","journal-title":"Reproduction"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"103137","DOI":"10.1016\/j.arcmed.2024.103137","article-title":"Laparoscopic Robotic Assisted Surgery in Reproductive Medicine","volume":"55","year":"2024","journal-title":"Arch. Med. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/REP-21-0022","article-title":"Mechanisms of ovarian aging","volume":"162","author":"Park","year":"2021","journal-title":"Reproduction"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13048-024-01427-y","article-title":"Ovarian aging: Energy metabolism of oocytes","volume":"17","author":"Bao","year":"2024","journal-title":"J. Ovarian Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1101\/gad.352732.125","article-title":"Studying ovarian aging and its health impacts: Modern tools and approaches","volume":"39","author":"Benayoun","year":"2025","journal-title":"Genes Dev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tem.2025.01.005","article-title":"Hallmarks of ovarian aging","volume":"36","author":"Wu","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e70481","DOI":"10.1002\/mco2.70481","article-title":"Ovarian Aging: Mechanisms, Age-Related Disorders, and Therapeutic Interventions","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ju, W., Zhao, Y., Yu, Y., Zhao, S., Xiang, S., and Lian, F. (2024). Mechanisms of mitochondrial dysfunction in ovarian aging and potential interventions. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1361289"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Cucinella, G., Gullo, G., Catania, E., Perino, A., Billone, V., Marinelli, S., Napoletano, G., and Zaami, S. (2024). Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks. J. Pers. Med., 14.","DOI":"10.3390\/jpm14020135"},{"key":"ref_110","first-page":"709","article-title":"Mesenchymal stem cells to treat female infertility; future perspective and challenges: A review","volume":"20","author":"Saeed","year":"2022","journal-title":"Int. J. Reprod. Biomed."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1574888X14666191119122159","article-title":"Effectiveness of Stem Cell Therapy in the Treatment of Ovarian Disorders and Female Infertility: A Systematic Review","volume":"15","author":"Ahmadian","year":"2020","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_112","first-page":"e38674","article-title":"Intraovarian Platelet-Rich Plasma Injections: Safety and Thoughts on Efficacy Based on a Single Centre Experience with 469 Women","volume":"15","author":"Fraidakis","year":"2023","journal-title":"Cureus"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Potiris, A., Stavros, S., Voros, C., Christopoulos, P., Pouliakis, A., Savvidis, M., Papapanagiotou, A., Karampitsakos, T., Topis, S., and Vrantza, T. (2024). Intraovarian Platelet-Rich Plasma Administration for Anovulatory Infertility: Preliminary Findings of a Prospective Cohort Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13175292"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13048-024-01423-2","article-title":"Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: A systematic review and meta-analysis","volume":"17","author":"Kekk","year":"2024","journal-title":"J. Ovarian Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Li, X., Liu, H., Lin, G., and Xu, L. (2023). The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: A systematic review and meta-analysis. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1292168"},{"key":"ref_116","first-page":"485","article-title":"Effect of intra-ovarian platelet rich plasma in women with poor ovarian response","volume":"14","author":"Ebrahimi","year":"2023","journal-title":"Casp. J. Intern. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"100273","DOI":"10.1016\/j.advnut.2024.100273","article-title":"Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis","volume":"15","author":"Shang","year":"2024","journal-title":"Adv. Nutr."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13048-022-01032-x","article-title":"The role of oxidative stress in ovarian aging: A review","volume":"15","author":"Yan","year":"2022","journal-title":"J. Ovarian Res."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Yang, L., Chen, Y., Liu, Y., Xing, Y., Miao, C., Zhao, Y., Chang, X., and Zhang, Q. (2021). The Role of Oxidative Stress and Natural Antioxidants in Ovarian Aging. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.617843"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"pgac310","DOI":"10.1093\/pnasnexus\/pgac310","article-title":"Reprogramming of ovarian aging epigenome by resveratrol","volume":"2","author":"Gou","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.18632\/aging.204157","article-title":"Short-term resveratrol treatment restored the quality of oocytes in aging mice","volume":"14","author":"Okamoto","year":"2022","journal-title":"Aging"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Wang, J., Jia, R., Celi, P., Zhuo, Y., Ding, X., Zeng, Q., Bai, S., Xu, S., Yin, H., and Lv, L. (2022). Resveratrol Alleviating the Ovarian Function Under Oxidative Stress by Alternating Microbiota Related Tryptophan-Kynurenine Pathway. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.911381"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10815-016-0751-z","article-title":"Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?","volume":"33","author":"Kizilkale","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Yang, L., Wang, H., Song, S., Xu, H., Chen, Y., Tian, S., Zhang, Y., and Zhang, Q. (2022). Systematic Understanding of Anti-Aging Effect of Coenzyme Q10 on Oocyte Through a Network Pharmacology Approach. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.813772"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00404-011-2169-2","article-title":"Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilization and embryo grading","volume":"285","author":"Turi","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Maldonado-C\u00e1rceles, A.B., Souter, I., Li, M.C., Mitsunami, M., Dimitriadis, I., Ford, J.B., M\u00ednguez-Alarc\u00f3n, L., and Chavarro, J.E. (2025). Antioxidant Intake and Ovarian Reserve in Women Attending a Fertility Center. Nutrients, 17.","DOI":"10.3390\/nu17030554"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Tesarik, J. (2021). Towards Personalized Antioxidant Use in Female Infertility: Need for More Molecular and Clinical Studies. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121933"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Li, X., Wang, Z., Wang, H., Xu, H., Sheng, Y., and Lian, F. (2022). Role of N-acetylcysteine treatment in women with advanced age undergoing IVF\/ICSI cycles: A prospective study. Front. Med., 9.","DOI":"10.3389\/fmed.2022.917146"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/humrep\/des019","article-title":"Delay in oocyte aging in mice by the antioxidant N-acetyl-L-cysteine (NAC)","volume":"27","author":"Liu","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.18632\/aging.102016","article-title":"Metformin prevents murine ovarian aging","volume":"11","author":"Qin","year":"2019","journal-title":"Aging"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"eabq1475","DOI":"10.1126\/sciadv.abq1475","article-title":"Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice","volume":"8","author":"Landry","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/ejendo\/lvad098","article-title":"The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Melin","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: An overview","volume":"122","author":"Viollet","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1262\/jrd.2022-001","article-title":"Rapamycin maintains the primordial follicle pool and protects ovarian reserve against cyclophosphamide-induced damage","volume":"68","author":"Chen","year":"2022","journal-title":"J. Reprod. Dev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddp483","article-title":"Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles","volume":"19","author":"Adhikari","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11357-019-00087-x","article-title":"Effect of caloric restriction and rapamycin on ovarian aging in mice","volume":"41","author":"Garcia","year":"2019","journal-title":"GeroScience"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/acel.12617","article-title":"Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice","volume":"16","author":"Dou","year":"2017","journal-title":"Aging Cell"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gene.2013.03.039","article-title":"Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression","volume":"523","author":"Zhang","year":"2013","journal-title":"Gene"},{"key":"ref_139","first-page":"561","article-title":"Impact of Ovarian Aging in Reproduction: From Telomeres and Mice Models to Ovarian Rejuvenation","volume":"93","author":"Polonio","year":"2020","journal-title":"Yale J. Biol. Med."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Toupance, S., Fattet, A.J., Thornton, S.N., Benetos, A., Gu\u00e9ant, J.L., and Koscinski, I. (2021). Ovarian Telomerase and Female Fertility. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070842"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00404-004-0690-2","article-title":"Is telomere length one of the determinants of reproductive life span?","volume":"272","author":"Aydos","year":"2005","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Reiter, R.J., Sharma, R., Romero, A., Manucha, W., Tan, D.-X., Zuccari, D.A.P.d.C., and Chuffa, L.G.d.A. (2023). Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue. Antioxidants, 12.","DOI":"10.3390\/antiox12030695"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s42003-021-02042-z","article-title":"Melatonin delays ovarian aging in mice by slowing down the exhaustion of ovarian reserve","volume":"4","author":"Yang","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e12381","DOI":"10.1111\/jpi.12381","article-title":"Long-term melatonin treatment delays ovarian aging","volume":"62","author":"Tamura","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/09513590.2021.1974378","article-title":"Oral melatonin supplementation during in vitro fertilization treatment: A systematic PRISMA review and meta-analysis of randomized controlled trials","volume":"37","author":"Mejlhede","year":"2021","journal-title":"Gynecol. Endocrinol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.mjafi.2014.12.022","article-title":"Dehydroepiandrosterone: A panacea for the ageing ovary?","volume":"71","author":"Naredi","year":"2015","journal-title":"Med. J. Armed Forces India"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1477-7827-9-67","article-title":"Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)","volume":"9","author":"Gleicher","year":"2011","journal-title":"Reprod. Biol. Endocrinol. RBE"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5582\/bst.2015.01154","article-title":"Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries","volume":"9","author":"Zhang","year":"2015","journal-title":"Biosci. Trends"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s43032-024-01473-3","article-title":"Mechanism Research of DHEA Treatment Improving Diminished Ovarian Reserve by Attenuating the AMPK-SIRT1 Signaling and Mitophagy","volume":"31","author":"Ma","year":"2024","journal-title":"Reprod. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lfs.2018.03.021","article-title":"Effects of dehydroepiandrosterone on the ovarian reserve and pregnancy outcomes in perimenopausal rats (DHEA and fertility in perimenopausal rats)","volume":"199","author":"Mahmoud","year":"2018","journal-title":"Life Sci."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12672-025-02062-9","article-title":"Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer","volume":"16","author":"Saripilli","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12951-022-01566-8","article-title":"Biomaterials and advanced technologies for the evaluation and treatment of ovarian aging","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Geng, Z., Guo, H., Li, Y., Liu, Y., and Zhao, Y. (2023). Stem cell-derived extracellular vesicles: A novel and potential remedy for primary ovarian insufficiency. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1090997"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s43587-024-00770-5","article-title":"Perspectives on biomarkers of reproductive aging for fertility and beyond","volume":"4","author":"Wang","year":"2024","journal-title":"Nat. Aging"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/GME.0000000000000755","article-title":"Aging ovary and the role for advanced glycation end products","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/humrep\/det419","article-title":"Advanced glycation end products and their receptor contribute to ovarian ageing","volume":"29","author":"Stensen","year":"2014","journal-title":"Hum. Reprod."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:33:45Z","timestamp":1768300425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":156,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["medicina62010157"],"URL":"https:\/\/doi.org\/10.3390\/medicina62010157","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}